Albany Molecular Research Financials

Based on the analysis of Albany Molecular's profitability, liquidity, and operating efficiency, Albany Molecular Research is not in a good financial situation at the moment. It has a very high risk of going through financial straits in May.
With this module, you can analyze Albany financials for your investing period. You should be able to track the changes in Albany Molecular individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Albany Molecular Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Albany Molecular's financial statements are interrelated, with each one affecting the others. For example, an increase in Albany Molecular's assets may result in an increase in income on the income statement.
The data published in Albany Molecular's official financial statements usually reflect Albany Molecular's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Albany Molecular Research. For example, before you start analyzing numbers published by Albany accountants, it's critical to develop an understanding of what Albany Molecular's liquidity, profitability, and earnings quality are in the context of the Albany space in which it operates.
Please note, the presentation of Albany Molecular's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Albany Molecular's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Albany Molecular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Albany Molecular Research. Please utilize our Beneish M Score to check the likelihood of Albany Molecular's management manipulating its earnings.

Albany Molecular Stock Summary

Albany Molecular competes with Dow Jones, Playstudios, Blue Hat, Hf Foods, and Playtika Holding. Albany Molecular Research, Inc., a contract research and manufacturing company, offer integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address26 Corporate Circle,
BenchmarkNYSE Composite
Websitewww.amriglobal.com
Phone518 512 2000
You should never invest in Albany Molecular without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Albany Stock, because this is throwing your money away. Analyzing the key information contained in Albany Molecular's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Albany Molecular Key Financial Ratios

Generally speaking, Albany Molecular's financial ratios allow both analysts and investors to convert raw data from Albany Molecular's financial statements into concise, actionable information that can be used to evaluate the performance of Albany Molecular over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Albany Molecular Research reports annually and quarterly.

Albany Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Albany Molecular's current stock value. Our valuation model uses many indicators to compare Albany Molecular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Albany Molecular competition to find correlations between indicators driving Albany Molecular's intrinsic value. More Info.
Albany Molecular Research is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Albany Molecular by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Albany Molecular's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Albany Molecular's earnings, one of the primary drivers of an investment's value.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Albany Stock

If you are still planning to invest in Albany Molecular Research check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albany Molecular's history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data